Adding Insult to Injury

The US government shutdown further hampered a research enterprise already struggling because of the sequester.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, AGNOSTICPREACHERSKIDFor more than two weeks in October, thousands of scientists employed by the Centers for Disease Control and Prevention, the National Institutes of Health, the Environmental Protection Agency, NASA, and other federal agencies stayed home as lawmakers bickered over government budgets. In a new report, the White House's Office of Management and Budget details the impact of the shutdown—from delaying field testing on invasive carp species in the Great Lakes to blocking the initiation of seven new clinical trials.

As if prohibiting astronomical observations, trashing field work in Antarctica, and putting a stop to new grant funding weren't enough, research in the U.S. was already working under the constraints of a sequestration that chopped federal funding earlier in the year. A new survey, conducted by the Association of American Universities, the Association of Public and Land-grant Universities, and The Science Coalition, of 74 leaders at research universities has found that 70 percent of responding institutions are experiencing delays in research projects as a result of the sequester. Federal cuts have also led to layoffs: 30 percent of survey participants said that part-time staff have had to go; 24 percent said that postdoctoral researchers have been fired; and 16 percent said that the sequestration has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies